Serendipity for the intervention of COVID-19 and prostatic adenocarcinoma (PaC).

Naseer, Faiza; Ahmad, Tahir; Gul, Rabia; Anjum, Sadia

Naseer, Faiza; Ahmad, Tahir; Gul, Rabia; Anjum, Sadia.

Naseer F; Atta-Ur-Rahman School of Applied Biosciences, Department of Industrial Biotechnology, National University of Science and Technology, Islamabad, Pakistan. faiza.naseer@ymail.com.
Ahmad T; Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan. faiza.naseer@ymail.com.
Gul R; Atta-Ur-Rahman School of Applied Biosciences, Department of Industrial Biotechnology, National University of Science and Technology, Islamabad, Pakistan. baig42@gmail.com.
Anjum S; Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

Prostate Cancer Prostatic Dis ; 25(1): 123-125, 2022 03.

Article in English | MEDLINE | ID: covidwho-1735218

Subject(s)

Adenocarcinoma; COVID-19; Prostatic Neoplasms; Adenocarcinoma/pathology; Adenocarcinoma/surgery; Humans; Male; Prostatectomy; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/pathology; Prostatic Neoplasms/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / COVID-19 Type of study: Diagnostic study / Experimental Studies Limits: Humans / Male Language: English Journal: Prostate Cancer Prostatic Dis Journal subject: Endocrinology / Neoplasms / Urology Year: 2022 Document Type: Article Affiliation country: S41391-022-00502-Z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google